Mastitis. Inflammatory disorders of breast
Conditions
Interventions
Intervention 1: Individuals in intervention group will be treated with a topical curcumin cream (200mg per pump) as an anti-inflammatory agent. Patients will be asked to apply one pump of the cream to
Treatment - Drugs
Placebo
Individuals in intervention group will be treated with a topical curcumin cream (200mg per pump) as an anti-inflammatory agent. Patients will be asked to apply one pump of the cream to the affected br
In placebo group, individuals will be prescribed with a topical moisturizer cream as the placebo (placebo group) and the treatment course is similar to the intervention group
Sponsors
Shiraz University of Midical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Breast feeding women with aged 20-40 years old; Breast feeding women with inflammatory symptoms of breast during lactation; Patients with inflammation scored 8-14 based of inflammation severity index. Exclusion Criteria: women with breast abscess, breast engorgement, blocked duct and galactocelle; Individuals who has a previous history of mastitis, recent trauma to the affected breast, breast surgery, inflammatory skin diseases and recurrent mastitis; Mothers who has taken systemic antibiotics in the recent 2 months.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inflammation severity. Timepoint: Before and 24h, 48h, 72h after intervention. Method of measurement: Inflammation severity index. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain Severity. Timepoint: Before and 24h, 48, 72h after intervention. Method of measurement: Visual analogue scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Pouya Farhadi
Shiraz University of Medical Sciences
Outcome results
None listed